{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T18:32:05Z","timestamp":1795026725291,"version":"4.10.2"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100030902","name":"Martin-Luther-Universit\u00e4t Halle-Wittenberg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100030902","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>In Ethiopia, the Human Papillomavirus (HPV) type distribution is still not well characterized among women with Human Immunodeficiency Virus (HIV). This study aimed to assess the prevalence of HPV infection, determine the distribution of HPV genotypes, and examine the rate of abnormal findings from visual inspection with acetic acid (VIA) among HPV-positive women living with HIV (WWH) in Addis Ababa, Ethiopia. It also analyzed the factors associated with these findings.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methodology<\/jats:title>\n            <jats:p>A retrospective record review was conducted at 16 HPV-DNA testing health facilities in Addis Ababa, Ethiopia. A total of 3303 WWH were screened for HPV infection through self- and clinician-based cervical swab collection from April 2021 to January 2022, all were included in the study. WWH were offered HPV testing at antiretroviral therapy (ART) clinics. Trained nurses invited women positive for high-risk HPV (hrHPV) types for VIA screening. Women with suspicious lesions were referred to gynaecologic centres, and others were appointed for a follow-up visit after one year. Associations between independent variables and HPV-DNA as well as VIA positivity were assessed using Binary logistic regression.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Result<\/jats:title>\n            <jats:p>The prevalence of hrHPV infection was 28.7% (95% CI: 27.2, 30.3%). Of those, 145 (15.3%) had HPV 16, and 38 (4%) had HPV 18 and the rest larger proportion was \u201cother high-risk HPV\u201d accounted for 695 (73.3%). The data showed that 70 (7.4%) women had multiple hrHPV infection, meaning\u2009\u2265\u20092 HPV DNA types were found in a single sample. This study found that the odds of women aged 25\u201329 being infected with hrHPV was 68% higher than those of women aged 40\u201349 (Adjusted Odds Ratio (AOR)\u2009=\u20091.68, 95% CI 1.26, 2.22). Women who were married and widowed had lower odds of hrHPV infection as compared to divorced women. Out of 948 hrHPV-positive clients, 786 (82.9%) had a follow up VIA screening, of which 15.5% (122) were found to be VIA positive. A history of STI was significantly associated with VIA positivity (AOR\u2009=\u20091.69, 95% CI 1.12, 2.54).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The prevalence of hrHPV in WWH was high as compared to other studies done in Ethiopia, particularly that of HPV 16 and \u201cother hrHPV\u201d. Prevalence of cervical lesion based on VIA was higher as compared to other studies that did not initially screen for hrHPV infection. This underlines the need to offer screening services to WWH and further characterize the other hrHPV. Screening for cervical lesions is of particular importance in women who report a history of STIs.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12885-025-14832-3","type":"journal-article","created":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T07:31:58Z","timestamp":1760340718000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Prevalence and factors associated with high-risk human papillomavirus infection and cervical lesions among women with HIV in Addis Ababa, Ethiopia"],"prefix":"10.1186","volume":"25","author":[{"given":"Helen Negassi","family":"Tesfom","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muluken","family":"Gizaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengistu","family":"Yilam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna M. A.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva J.","family":"Kantelhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sefonias","family":"Getachew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,13]]},"reference":[{"issue":"3","key":"14832_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A cancer. J Clin. 2024;74(3):229\u201363.","journal-title":"J Clin"},{"key":"14832_CR2","doi-asserted-by":"publisher","unstructured":"De Vuyst H, Alemany L, Lacey C, Chibwesha CJ, Sahasrabuddhe V, Banura C, et al. The burden of human papillomavirus infections and related diseases insub-saharan Africa. Vaccine. 2013;31 Suppl 5(0 5):F32\u201346. https:\/\/doi.org\/10.1016\/j.vaccine.2012.07.092.","DOI":"10.1016\/j.vaccine.2012.07.092"},{"key":"14832_CR3","unstructured":"Ferlay JEM, Lam F, Laversanne M, Colombet M, Mery L, Pi\u00f1eros M, et al. Global Cancer Observatory: Cancer Today Lyon, France: International Agency for Research on Cancer; 2024 [Available from: https:\/\/gco.iarc.who.int\/today"},{"key":"14832_CR4","doi-asserted-by":"publisher","unstructured":"Clifford GM, Gon\u00e7alves MA, Franceschi S; HPV andHIV Study Group. Human papillomavirus types among women infected with HIV: a meta-analysis. AIDS. 2006;20(18):2337\u201344. https:\/\/doi.org\/10.1097\/01.aids.0000253361.63578.14.","DOI":"10.1097\/01.aids.0000253361.63578.14"},{"key":"14832_CR5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/infdis\/jis299","volume":"206","author":"Z Mbulawa","year":"2012","unstructured":"Mbulawa Z, Marais D, Johnson L, Coetzee D, Williamson A-L. Impact of human immunodeficiency virus on the natural history of human papillomavirus genital infection in South African men and women. J Infect Dis. 2012;206:15\u201327.","journal-title":"J Infect Dis"},{"issue":"6","key":"14832_CR6","first-page":"7629","volume":"14","author":"E Tartaglia","year":"2017","unstructured":"Tartaglia E, Falasca K, Vecchiet J, Sabusco GP, Picciano G, Di Marco R, et al. Prevalence of HPV infection among HIV-positive and HIV-negative women in central\/eastern italy: strategies of prevention. Oncol Lett. 2017;14(6):7629\u201335.","journal-title":"Oncol Lett"},{"key":"14832_CR7","unstructured":"Bruni L, Albero G, Serrano B, Mena M, G\u00f3mez D, Mu\u00f1oz J et al. Human Papillomavirus and Related Diseases in Ethiopia. Barcelona: ICO\/IARC Information Centre on HPV and Cancer (HPV Information Centre). 2019; 2019."},{"issue":"10","key":"14832_CR8","doi-asserted-by":"publisher","first-page":"e48108","DOI":"10.1371\/journal.pone.0048108","volume":"7","author":"A Tanon","year":"2012","unstructured":"Tanon A, Jaquet A, Ekouevi DK, Akakpo J, Adoubi I, Diomande I, et al. The spectrum of cancers in West Africa: associations with human immunodeficiency virus. PLoS One. 2012;7(10):e48108-e.","journal-title":"PLoS One"},{"issue":"1","key":"14832_CR9","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1750-9378-9-33","volume":"9","author":"S-R Leyh-Bannurah","year":"2014","unstructured":"Leyh-Bannurah S-R, Prugger C, de Koning MN, Goette H, Lell\u00e9 RJ. Cervical human papillomavirus prevalence and genotype distribution among hybrid capture 2 positive women 15 to 64 years of age in the Gurage Zone, rural Ethiopia. Infect Agents Cancer. 2014;9(1):33.","journal-title":"Infect Agents Cancer"},{"key":"14832_CR10","first-page":"49","volume":"Suppl 1","author":"W Mihret","year":"2014","unstructured":"Mihret W, Yusuf L, Abebe M, Yamuah LK, Bekele L, Abate E, et al. A pilot study on detection and genotyping of humanpapilloma virus isolated from clinically diagnosed Ethiopian women having cervical intraepithelial neoplasia. Ethiop Med J. 2014;Suppl 1:49\u201352.","journal-title":"Ethiop Med J"},{"issue":"1","key":"14832_CR11","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12985-022-01741-1","volume":"19","author":"A Derbie","year":"2022","unstructured":"Derbie A, Mekonnen D, Nibret E, Maier M, Woldeamanuel Y, Abebe T. Human papillomavirus genotype distribution in Ethiopia: an updated systematic review. Virol J. 2022;19(1):13.","journal-title":"Virol J"},{"key":"14832_CR12","doi-asserted-by":"publisher","unstructured":"Dartell M, Rasch V, Munk C, Kahesa C, Mwaiselage J, Iftner T, et al. Risk factors for high-risk human papillomavirus detection among HIV-negative and HIV-positive women from Tanzania. Sexually Transmitted Diseases. 2013;40(9):737-43. https:\/\/doi.org\/10.1097\/OLQ.0000000000000005.","DOI":"10.1097\/OLQ.0000000000000005"},{"issue":"3","key":"14832_CR13","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1093\/jnci\/91.3.226","volume":"91","author":"JM Palefsky","year":"1999","unstructured":"Palefsky JM, Minkoff H, Kalish LA, Levine A, Sacks HS, Garcia P, et al. Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women. JNCI J Natl Cancer Inst. 1999;91(3):226\u201336.","journal-title":"JNCI J Natl Cancer Inst"},{"key":"14832_CR14","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1186\/s12885-020-07344-9","volume":"20","author":"G Hailemariam","year":"2020","unstructured":"Hailemariam G, Gebreyesus H, Woldearegay T, Gebremichael T, Gebrecherkos K, Shfare M, et al. Magnitude and associated factors of VIA positive test results for cervical cancer screening among refugee women aged 25\u201349 years in North Ethiopia. BMC Cancer. 2020;20:858.","journal-title":"BMC Cancer"},{"key":"14832_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0084519","author":"A Gedefaw","year":"2013","unstructured":"Gedefaw A, Astatkie A, Tessema GA. The prevalence of precancerous cervical cancer lesion among HIV-infected women in southern Ethiopia: a cross-sectional study. PLoS One. 2013. https:\/\/doi.org\/10.1371\/journal.pone.0084519.","journal-title":"PLoS One"},{"key":"14832_CR16","doi-asserted-by":"publisher","unstructured":"Vinodhini K, ShanmughapriyaS, Das BC, Natarajaseenivasan K. Prevalence and risk factors of HPV infection among womenfrom various provinces of the world. Arch Gynecol Obstet. 2012;285(3):771\u20137. https:\/\/doi.org\/10.1007\/s00404-011-2155-8.\u00a0","DOI":"10.1007\/s00404-011-2155-8"},{"key":"14832_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.33278","author":"BA-O Teka","year":"2021","unstructured":"Teka BA-O, Gizaw MA-O, Ruddies F, Addissie AA-O, Chanyalew Z, Skof AS, et al. Population-based human papillomavirus infection and genotype distribution among women in rural areas of South central Ethiopia. Int J Cancer. 2021. https:\/\/doi.org\/10.1002\/ijc.33278.","journal-title":"Int J Cancer"},{"key":"14832_CR18","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/S2055-6640(20)30065-0","volume":"5","author":"G Murenzi","year":"2019","unstructured":"Murenzi G. Preliminary Xpert\u00ae HPV testing results from a large study of women living with HIV in Rwanda. J Virus Eradication. 2019;5:6\u20137.","journal-title":"J Virus Eradication"},{"issue":"1","key":"14832_CR19","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1186\/s12879-015-1181-8","volume":"15","author":"ZZA Mbulawa","year":"2015","unstructured":"Mbulawa ZZA, Coetzee D, Williamson A-L. Human papillomavirus prevalence in South African women and men according to age and human immunodeficiency virus status. BMC Infect Dis. 2015;15(1):459.","journal-title":"BMC Infect Dis"},{"issue":"9","key":"14832_CR20","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1038\/bjc.2012.441","volume":"107","author":"H De Vuyst","year":"2012","unstructured":"De Vuyst H, Mugo NR, Chung MH, McKenzie KP, Nyongesa-Malava E, Tenet V, et al. Prevalence and determinants of human papillomavirus infection and cervical lesions in HIV-positive women in Kenya. Br J Cancer. 2012;107(9):1624\u201330.","journal-title":"Br J Cancer"},{"issue":"1","key":"14832_CR21","doi-asserted-by":"publisher","first-page":"e002231","DOI":"10.1136\/bmjgh-2019-002231","volume":"5","author":"YM Dessalegn","year":"2020","unstructured":"Dessalegn YM, Martin KM, Allysha C, Yohannes DW, Cheikh MF, Sarah N, et al. Adolescent sexual and reproductive health in sub-Saharan Africa: who is left behind? BMJ Glob Health. 2020;5(1):e002231.","journal-title":"BMJ Glob Health"},{"issue":"1","key":"14832_CR22","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1186\/s12889-021-10762-4","volume":"21","author":"M Semwogerere","year":"2021","unstructured":"Semwogerere M, Dear N, Tunnage J, Reed D, Kibuuka H, Kiweewa F, et al. Factors associated with sexually transmitted infections among care-seeking adults in the African cohort study. BMC Public Health. 2021;21(1):738.","journal-title":"BMC Public Health"},{"issue":"3","key":"14832_CR23","doi-asserted-by":"publisher","first-page":"e1004113","DOI":"10.1371\/journal.pcbi.1004113","volume":"11","author":"MD Ryser","year":"2015","unstructured":"Ryser MD, Myers ER, Durrett R. HPV clearance and the neglected role of stochasticity. PLoS Comput Biol. 2015;11(3):e1004113.","journal-title":"PLoS Comput Biol"},{"issue":"11","key":"14832_CR24","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1002\/jmv.21887","volume":"82","author":"MC Cercato","year":"2010","unstructured":"Cercato MC, Mariani L, Vocaturo A, Carrone A, Terrenato I, Morano G, et al. Predictors of human papilloma virus (HPV) infection in Italian women. J Med Virol. 2010;82(11):1921\u20137.","journal-title":"J Med Virol"},{"key":"14832_CR25","doi-asserted-by":"publisher","unstructured":"Krings AA-O, Dunyo P, Pesic A, Tetteh S, Hansen B, Gedzah I, et al. Characterization of human papillomavirus prevalence and risk factors to guide cervical cancer screening in the North Tongu District, Ghana. PLoS One. 2019(6). https:\/\/doi.org\/10.1371\/journal.pone.0218762.","DOI":"10.1371\/journal.pone.0218762"},{"key":"14832_CR26","doi-asserted-by":"crossref","unstructured":"Temesgen MA-O, Alemu T, Shiferaw B, Legesse S, Zeru TA-O, Haile M et al. Prevalence of oncogenic human papillomavirus (HPV 16\/18) infection, cervical lesions and its associated factors among women aged 21\u201349 years in Amhara region, Northern Ethiopia. (1932\u20136203 (Electronic)).","DOI":"10.1371\/journal.pone.0248949"},{"key":"14832_CR27","unstructured":"D MB, editor. Prevalence and Determinants of Pre-Cancerous Cervical Lesion and Human Papillomavirus Among HIV-Infected and HIV-Uninfected Women in North-West Ethiopia: A Comparative Retrospective Cross-Sectional Study. Dove; 2021."},{"issue":"3","key":"14832_CR28","first-page":"4","volume":"13","author":"T Belayneh","year":"2019","unstructured":"Belayneh T, Mitiku H, Weldegebreal F. Precancerous cervical lesion and associated factors among HIV-infected women on ART in Amhara regional state, Ethiopia: a hospital-based cross-sectional study. Int J Health Sci (Qassim). 2019;13(3):4\u20139.","journal-title":"Int J Health Sci (Qassim)"},{"issue":"1","key":"14832_CR29","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13027-020-00323-6","volume":"15","author":"EO Orang\u2019o","year":"2020","unstructured":"Orang\u2019o EO, Were E, Rode O, Muthoka K, Byczkowski M, Sartor H, et al. Novel concepts in cervical cancer screening: a comparison of VIA, HPV DNA test and p16INK4a\/Ki-67 dual stain cytology in Western Kenya. Infect Agents Cancer. 2020;15(1):57.","journal-title":"Infect Agents Cancer"},{"key":"14832_CR30","doi-asserted-by":"publisher","DOI":"10.1177\/1073274819845872","author":"F Weldegebreal","year":"2019","unstructured":"Weldegebreal F, Worku T. Precancerous cervical lesion among HIV-positive women in sub-Saharan Africa: a systematic review and meta-analysis. Cancer Control. 2019. https:\/\/doi.org\/10.1177\/1073274819845872.","journal-title":"Cancer Control"},{"key":"14832_CR31","doi-asserted-by":"publisher","unstructured":"Vedantham H, Silver MI, Kalpana B, Rekha C, Karuna BP, Vidyadhari K, et al. CATCH Study Team. Determinants of VIA (Visual Inspection of the Cervix After Acetic Acid Application) positivity in cervical cancer screening of women in a peri-urban area in Andhra Pradesh, India. Cancer Epidemiol Biomarkers Prev. 2010;19(5):1373\u201380. https:\/\/doi.org\/10.1158\/1055-9965.","DOI":"10.1158\/1055-9965"},{"key":"14832_CR32","doi-asserted-by":"publisher","unstructured":"Davis-Dao CA, Cremer M, Felix J, Cortessis VK. Effect of cervicitis on visual inspection with acetic acid. J Low Genit Tract Dis. 2008;12(4):282\u20136. https:\/\/doi.org\/10.1097\/LGT.0b013e31816d1da4.","DOI":"10.1097\/LGT.0b013e31816d1da4"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14832-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14832-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14832-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T07:32:01Z","timestamp":1760340721000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-14832-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,13]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14832"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14832-3","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,13]]},"assertion":[{"value":"21 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted after ethical clearance was obtained from Addis Ababa University School of Public Health Research and Ethical Committee (REC) with approval number (SPHE001\/21). Ethical Clearance was also obtained from Addis Ababa Health Bureau Public Health Research and Emergency Management Directorate. It was secondary data and fully anonymous. Therefore, informed consent is waived\/deemed unnecessary by the ethics committee (School of Public Health Research and Ethical Committee (REC)). However, permission to conducted the study was obtained from the management of the 16 health facilities after detail information about the study. The confidentiality of the data has been maintained throughout the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1557"}}